Laboratorios Richmond SACIF (RICH) - Total Assets

Latest as of September 2025: AR$354.98 Billion ARS ≈ $256.86 Million USD

Based on the latest financial reports, Laboratorios Richmond SACIF (RICH) holds total assets worth AR$354.98 Billion ARS (≈ $256.86 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Laboratorios Richmond SACIF - Total Assets Trend (2006–2024)

This chart illustrates how Laboratorios Richmond SACIF's total assets have evolved over time, based on quarterly financial data. Also see Laboratorios Richmond SACIF (RICH) total market value for the company's overall valuation and market capitalisation.

Laboratorios Richmond SACIF - Asset Composition Analysis

Current Asset Composition (December 2024)

Laboratorios Richmond SACIF's total assets of AR$354.98 Billion consist of 26.4% current assets and 73.6% non-current assets. Review Laboratorios Richmond SACIF (RICH) total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (ARS)	% of Total Assets
Cash & Equivalents	AR$0.00	2.7%
Accounts Receivable	AR$28.17 Billion	10.8%
Inventory	AR$25.39 Billion	9.8%
Property, Plant & Equipment	AR$0.00	0.0%
Intangible Assets	AR$26.08 Billion	10.0%
Goodwill	AR$4.16 Billion	1.6%

Asset Composition Trend (2006–2024)

This chart illustrates how Laboratorios Richmond SACIF's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Laboratorios Richmond SACIF stock quote for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Laboratorios Richmond SACIF's current assets represent 26.4% of total assets in 2024, an increase from 0.0% in 2006.
Cash Position: Cash and equivalents constituted 2.7% of total assets in 2024, down from 6.2% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 10.8% of total assets.

Laboratorios Richmond SACIF Competitors by Total Assets

Key competitors of Laboratorios Richmond SACIF based on total assets are shown below.

Company	Country	Total Assets
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	India	Rs443.12 Billion
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥29.95 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	China	CN¥12.75 Billion
Harbin Pharmaceutical Group Co Ltd SHG:600664	China	CN¥14.08 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion

Laboratorios Richmond SACIF - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.05	1.23	1.51
Quick Ratio	0.60	0.74	1.06
Cash Ratio	0.00	0.00	0.00
Working Capital	AR$4.32 Billion	AR$10.88 Billion	AR$1.82 Billion

Laboratorios Richmond SACIF - Advanced Valuation Insights

This section examines the relationship between Laboratorios Richmond SACIF's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.25
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	-22.9%
Total Assets	AR$260.15 Billion
Market Capitalization	$75.88 Million USD

Valuation Analysis

Below Book Valuation: The market values Laboratorios Richmond SACIF's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Laboratorios Richmond SACIF's assets decreased by 22.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Laboratorios Richmond SACIF (2006–2024)

The table below shows the annual total assets of Laboratorios Richmond SACIF from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	AR$260.15 Billion ≈ $188.25 Million	-22.88%
2023-12-31	AR$337.32 Billion ≈ $244.09 Million	+728.40%
2022-12-31	AR$40.72 Billion ≈ $29.47 Million	+58.49%
2021-12-31	AR$25.69 Billion ≈ $18.59 Million	+215.90%
2020-12-31	AR$8.13 Billion ≈ $5.89 Million	+58.40%
2019-12-31	AR$5.13 Billion ≈ $3.72 Million	+89.81%
2018-12-31	AR$2.71 Billion ≈ $1.96 Million	+74.23%
2017-12-31	AR$1.55 Billion ≈ $1.12 Million	+80.30%
2016-12-31	AR$861.13 Million ≈ $623.12K	+61.61%
2015-12-31	AR$532.83 Million ≈ $385.56K	+38.16%
2014-12-31	AR$385.66 Million ≈ $279.06K	+34.20%
2013-12-31	AR$287.37 Million ≈ $207.94K	+6.06%
2012-12-31	AR$270.95 Million ≈ $196.06K	+70.39%
2011-12-31	AR$159.03 Million ≈ $115.07K	+17.12%
2010-12-31	AR$135.78 Million ≈ $98.25K	+6.21%
2009-12-31	AR$127.84 Million ≈ $92.51K	+27.03%
2008-12-31	AR$100.63 Million ≈ $72.82K	+29.71%
2007-12-31	AR$77.58 Million ≈ $56.14K	+37.67%
2006-12-31	AR$56.36 Million ≈ $40.78K	--

About Laboratorios Richmond SACIF

BA:RICH Argentina Drug Manufacturers - Specialty & Generic

Market Cap

$75.88 Million

AR$104.87 Billion ARS

Market Cap Rank

#20385 Global

#55 in Argentina

Share Price

AR$1575.00

Change (1 day)

+0.96%

52-Week Range

AR$992.50 - AR$2165.00

All Time High

AR$2165.00